Arş. Gör. Fatih SELÇUKBİRİCİK

Yayın Ağı

Makaleler 34

1. Hormon reseptörü pozitif, HER2 negatif metastatik meme kanseri tanısıyla ribosiklib veya palbosiklib ile letrozol kombinasyon tedavisi verilen hastalarda HER2-düşük ekspresyonunun önemi

kahraman s., Hizal M., Gumusay O., Basaran G., Seyyar M., Sahin E., et al.

Turkish Journal of Clinics and Laboratory , cilt.16, sa.2, ss.255-262, 2025 (Hakemli Dergi)

2. Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer

Kahraman S., Erul E., Seyyar M., GÜMÜŞAY Ö., Bayram E., Demirel B. C., et al.

Future oncology (London, England) , cilt.19, sa.10, ss.727-736, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

3. Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

Karacin C., Oksuzoglu B., Demirci A., KESKİNKILIÇ M., Baytemür N. K., Yılmaz F., et al.

BMC cancer , cilt.23, sa.1, ss.136, 2023 (SCI-Expanded)

4. Crizotinib efficacy and safety in patients with advanced NSCLC harboring MET alterations: A real-life data of Turkish Oncology Group

GÜRBÜZ M., Kilickap S., BİLİCİ A., Karadurmus N., Sezer A., ŞENDUR M. A. N., et al.

MEDICINE , cilt.101, sa.50, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

5. Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group

Gurbuz M., Kutlu Y., AKKUŞ E., KÖKSOY E. B., Kose N., Oven B. B., et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , cilt.148, sa.12, ss.3547-3555, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

6. Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study

Hizal M., Bilgin B., Paksoy N., Kilickap S., Atci M. M., KAHRAMAN S., et al.

FUTURE ONCOLOGY , cilt.18, ss.2573-2582, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

7. Nivolumab for metastatic uveal melanoma: a multicenter, retrospective study

Tacar S. Y., Selcukbiricik F., Yilmaz M., Erturk K., Sarici A. M., Gulturk I., et al.

MELANOMA RESEARCH , cilt.31, sa.5, ss.449-455, 2021 (SCI-Expanded)

8. Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab

Tural D., Olmez O. F., Sumbul A. T., Ozhan N., ÇAKAR B., Kostek O., et al.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , cilt.26, ss.1506-1513, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

9. Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma.

Tural D., Olmez O. F., Sumbul A. T., Artac M., Ozhan N., Akar E., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.39, sa.6, 2021 (SCI-Expanded)

10. Determine the impact of hybrid capture-based comprehensive genomic profiling (CGP) on the treatment strategies in patients with solid tumors: A national, multicenter, retrospective study.

Disel U., Kose F., Bilici A., Ozguroglu M., Saglam S., Seker M., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.38, sa.15, 2020 (SCI-Expanded)

11. Prognostic factors for survival in metastatic renal cell carcinoma patients with brain metastases receiving targeted therapy

YILDIZ İ., Bilici A., Karadurmus N., Ozer L., Tural D., Kaplan M. A., et al.

TUMORI J , cilt.104, sa.6, ss.444-450, 2018 (SCI-Expanded)

12. Combination Technique Is Superior to Dye Alone in Identification of the Sentinel Lymph Node in Male Breast Cancer

Simsek O., Belli A. K., Aydogan F., Karatas A., Canbay E., Kepil N., et al.

AMERICAN SURGEON , cilt.84, sa.12, ss.1957-1960, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

13. Clinical and pathological characteristics and their effect on survival in elderly patients with gastrointestinal stromal tumors

Mandel N. M., Selcukbiricik F., Kanitez M., Yalcin S., Tural D., Erdamar S., et al.

JOURNAL OF BUON , cilt.21, sa.2, ss.360-365, 2016 (SCI-Expanded)

14. Is Perineural Invasio (PN) a Determinant of Disease Free Survival in Early Stage Colorectal Cancer?

Ozturk M. A., DANE F., Karagoz S., Tural D., Selcukbiricik F., Demirelli F., et al.

HEPATO-GASTROENTEROLOGY , cilt.62, sa.137, ss.59-64, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

15. Preoperative versus postoperative chemoradiotherapy in stage T3, N0 rectal cancer

Tural D., Selcukbiricik F., Yildiz O., Elcin O., Erdamar S., Guney S., et al.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , cilt.19, sa.5, ss.889-896, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

16. Is Her-2 Status in the Primary Tumor Correlated with Matched Lymph Node Metastases in Patients with Gastric Cancer Undergoing Curative Gastrectomy?

Selcukbiricik F., Erdamar S., Buyukunal E., Serrdengecti S., Demirelli F.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.24, ss.10607-10611, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

17. Hemophagocytic Syndrome Associated with Immune Reconstitution Inflammatory Syndrome in a Patient with AIDS Related Burkitt's Leukemia/Lymphoma

Kanitez M., Kapmaz M., Alpay N., Selcukbiricik F., ÇAĞATAY A. A., Diz-Kucukkaya R.

CASE REPORTS IN MEDICINE , cilt.2014, 2014 (ESCI) Sürdürülebilir Kalkınma

18. PET-CT changes the management and improves outcome in patients with recurrent colorectal cancer

Tural D., Selcukbiricik F., Sager S., Akar E., Yildiz O., Serdengecti S.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.10, sa.1, ss.121-126, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

19. Gastric cancer: A case study in Turkey

Tural D., Selcukbiricik F., Akar E., Serdengecti S., Buyukunal E.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.9, sa.4, ss.644-648, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

20. The Relation between Pathological Complete Response and Clinical Outcome in Patients with Rectal Cancer

Tural D., Selcukbiricik F., Ozturk M. A., Yildiz O., Turna H., Er-damar S., et al.

HEPATO-GASTROENTEROLOGY , cilt.60, sa.126, ss.1365-1370, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

21. Are high initial CEA and CA 19-9 levels associated with the presence of K-ras mutation in patients with metastatic colorectal cancer?

Selcukbiricik F., Bilici A., Tural D., Erdamar S., Soyluk Ö., Buyukunal E., et al.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine , cilt.34, sa.4, ss.2233-9, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

22. Association KRAS G13D Tumor Mutated Outcome in Patients with Chemotherapy Refractory Metastatic Colorectal Cancer Treated with Cetuximab

Tural D., Selcukbiricik F., Erdamar S., Ozkurt C. U., Yanmaz T., Mandel N. M., et al.

HEPATO-GASTROENTEROLOGY , cilt.60, sa.125, ss.1035-1040, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

23. Male Breast Cancer: 37-Year Data Study at a Single Experience Center in Turkey

Selcukbiricik F., Tural D., Aydogan F., Bese N., Buyukunal E., Serdengecti S.

JOURNAL OF BREAST CANCER , cilt.16, sa.1, ss.60-65, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

24. Gastrointestinal Stromal Tumors in Turkey: Experiences from 3 Centers

Selcukbiricik F., Yalcin S., Tural D., Erdamar S., Demir G., Dogusoy G., et al.

ONKOLOGIE , cilt.36, ss.18-24, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

25. Is Helicobacter pylori a Poor Prognostic Factor for HER-2 SISH Positive Gastric Cancer?

Selcukbiricik F., Tural D., Erdamar S., Buyukunal E., Demirelli F. H., Serdengecti S.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.14, sa.5, ss.3319-3322, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

26. Male Breast Cancers Behave Differently in Elderly Patients

Tural D., Selcukbiricik F., Aydogan F., Bese N., Yetmen O., Ilvan S., et al.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY , cilt.43, sa.1, ss.22-27, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

27. Clinicopathological Features and Localization of Gastric Cancers and their Effects on Survival in Turkey

Selcukbiricik F., Tural D., Bilici A., Uzel E. K., Ozguroglu M., Demirelli F., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.14, sa.1, ss.553-556, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

28. Selective transitional zone sampling approach versus random biopsy in cases with malignant liver masses: Is there any superiority?

Caliskan K. C., Ozguven B., Bugdaci M. S., Cakmakci E., Orhan U. P., Erturk M., et al.

Turkish Journal of Gastroenterology , cilt.23, sa.6, ss.708-713, 2012 (SCI-Expanded)

29. A comparison of patient characteristics, prognosis, treatment modalities, and survival according to age group in gastric cancer patients

Tural D., Selcukbiricik F., Serdengecti S., Buyukunal E.

WORLD JOURNAL OF SURGICAL ONCOLOGY , cilt.10, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma

30. Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome.

HIZ V. M. M., Tural ., Molinas M. N., Dervisoglu ., Dincbas F ., Koca ., et al.

Jpn J Clin Oncol , cilt.420-6, ss.1093, 2012 (Hakemli Dergi)

31. Perineural Invasion Independent Prognostic Factors in Patients with Gastric Cancer Undergoing Curative Resection

Selcukbiricik F., Tural D., Buyukual E., Serdengecti S.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.13, sa.7, ss.3149-3152, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma

32. Facial Nerve Palsy: An Unusual Presenting Feature of Small Cell Lung Cancer

Yildiz O., Buyuktas D., Ekiz E., Selcukbiricik F., PAPİLA İ., PAPİLA Ç.

CASE REPORTS IN ONCOLOGY , cilt.4, sa.1, ss.35-38, 2011 (ESCI) Sürdürülebilir Kalkınma

33. Association between reduced levels of MEFV messenger RNA in peripheral blood leukocytes and acute inflammation

Ustek D., EKMEKCI C. G., Selcukbiricik F., Cakiris A., OKU B., Vural B., et al.

ARTHRITIS AND RHEUMATISM , cilt.56, sa.1, ss.345-350, 2007 (SCI-Expanded)

34. Impaired brachial endothelial function in patients with primary anti-phospholipid syndrome

MERCANOGLU F., ERDOGAN D., OFLAZ H., KUCUKKAYA R., SELCUKBIRICIK F., GUL A., et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , cilt.58, sa.11, ss.1003-1007, 2004 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 3

1. Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experience

Tural D., Olmez O. F., Sumbul A. T., Artac M., Ozhan N., Akar E., et al.

Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San-Francisco, Kostarika, 13 - 15 Şubat 2020, cilt.38, (Özet Bildiri)

2. Prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer.

Bilici A., Selcukbiricik F., Ustaalioglu B. B. O., Tural D., Seker M., Gumus M., et al.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri) Sürdürülebilir Kalkınma

3. Thromboembolic complications in cancer patients.

Yenidunya G., Turna H., Ozturk M. A., Tural D., Selcukbiricik F., Yildiz O., et al.

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, (Özet Bildiri)

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

190

H-İndeks (WoS)

Atıf (Scopus)

209

H-İndeks (Scopus)

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler